BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 2689136)

  • 1. Octreotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion.
    Battershill PE; Clissold SP
    Drugs; 1989 Nov; 38(5):658-702. PubMed ID: 2689136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Octreotide, a new somatostatin analogue.
    Katz MD; Erstad BL
    Clin Pharm; 1989 Apr; 8(4):255-73. PubMed ID: 2653711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Octreotide long-acting release (LAR): a review of its use in the management of acromegaly.
    McKeage K; Cheer S; Wagstaff AJ
    Drugs; 2003; 63(22):2473-99. PubMed ID: 14609359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future.
    Öberg K; Lamberts SW
    Endocr Relat Cancer; 2016 Dec; 23(12):R551-R566. PubMed ID: 27697899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Somatostatin analog (octreotide) in clinical use: current and potential indications].
    Meier R; Dierdorf R; Gyr K
    Schweiz Med Wochenschr; 1992 Jun; 122(25):957-68. PubMed ID: 1621078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NIH conference. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut.
    Gorden P; Comi RJ; Maton PN; Go VL
    Ann Intern Med; 1989 Jan; 110(1):35-50. PubMed ID: 2535688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octreotide long-acting release (LAR). A review of its pharmacological properties and therapeutic use in the management of acromegaly.
    Gillis JC; Noble S; Goa KL
    Drugs; 1997 Apr; 53(4):681-99. PubMed ID: 9098666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future medical prospects for Sandostatin.
    Harris AG
    Z Gastroenterol; 1990 Sep; 28 Suppl 2():55-60. PubMed ID: 1980778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical use of octreotide (Sandostatin) in endocrinology].
    Prelević GM
    Med Pregl; 1993; 46(9-10):343-8. PubMed ID: 7997211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Debut of a somatostatin analog: octreotide in review.
    Zindel LR
    Conn Med; 1989 Dec; 53(12):741-4. PubMed ID: 2558839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of octreotide. Therapeutic applications in patients with pituitary tumours.
    Chanson P; Timsit J; Harris AG
    Clin Pharmacokinet; 1993 Nov; 25(5):375-91. PubMed ID: 8287633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging indications for octreotide therapy, Part 1.
    Mosdell KW; Visconti JA
    Am J Hosp Pharm; 1994 May; 51(9):1184-92. PubMed ID: 8042637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects.
    Harris AG
    Gut; 1994; 35(3 Suppl):S1-4. PubMed ID: 7911441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Octreotide: a synthetic analog of somatostatin.
    Rosenberg JM
    Drug Intell Clin Pharm; 1988 Oct; 22(10):748-54. PubMed ID: 3068036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of somatostatin analogues in the treatment of refractory diarrhoea.
    Farthing MJ
    Digestion; 1996; 57 Suppl 1():107-13. PubMed ID: 8813486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin and octreotide in gastroenterology.
    Burroughs AK; McCormick PA
    Aliment Pharmacol Ther; 1991 Aug; 5(4):331-41. PubMed ID: 1685674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Octreotide, analog of somatostatin. Pharmacological properties and therapeutic applications in pituitary endocrine tumors].
    Chanson P; Timsit J; Harris AG
    Presse Med; 1993 Dec; 22(40):2009-16. PubMed ID: 7907419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Novel pharmacologic therapies in acromegaly].
    Góth M; Hubina E; Kovács L; Szabolcs I
    Orv Hetil; 2002 May; 143(19 Suppl):1057-62. PubMed ID: 12063860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Octreotide: a long-acting somatostatin analog.
    Brown NJ
    Am J Med Sci; 1990 Oct; 300(4):267-73. PubMed ID: 2248280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological management of acromegaly: a current perspective.
    Manjila S; Wu OC; Khan FR; Khan MM; Arafah BM; Selman WR
    Neurosurg Focus; 2010 Oct; 29(4):E14. PubMed ID: 20887124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.